Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Onconeural ventral antigen 1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1)

 NOVA1_HUMAN             Reviewed;         510 AA.
P51513; A8K0S4; A8K4Q7; D3DS81; D3DS82; Q6B004;
01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
01-OCT-1996, sequence version 1.
22-NOV-2017, entry version 153.
RecName: Full=RNA-binding protein Nova-1;
AltName: Full=Neuro-oncological ventral antigen 1;
AltName: Full=Onconeural ventral antigen 1;
AltName: Full=Paraneoplastic Ri antigen;
AltName: Full=Ventral neuron-specific protein 1;
Name=NOVA1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
TISSUE=Cerebellum, and Hippocampus;
PubMed=8398153; DOI=10.1016/0896-6273(93)90077-5;
Buckanovich R.J., Posner J.B., Darnell R.B.;
"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding
protein and is specifically expressed in the developing motor
system.";
Neuron 11:657-672(1993).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
TISSUE=Amygdala;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=11181995; DOI=10.1126/science.1058040;
Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
"The sequence of the human genome.";
Science 291:1304-1351(2001).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-34.
TISSUE=Fetal brain;
Dmitrenko V.V., Garifulin O.M., Shostak K.A., Smikodub A.I.,
Kavsan V.M.;
Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
[7]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[8]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21406692; DOI=10.1126/scisignal.2001570;
Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
Blagoev B.;
"System-wide temporal characterization of the proteome and
phosphoproteome of human embryonic stem cell differentiation.";
Sci. Signal. 4:RS3-RS3(2011).
[9]
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 423-495.
PubMed=10368286; DOI=10.1016/S0969-2126(99)80025-2;
Lewis H.A., Chen H., Edo C., Buckanovich R.J., Yang Y.Y.-L.,
Musunuru K., Zhong R., Darnell R.B., Burley S.K.;
"Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding
domains.";
Structure 7:191-203(1999).
-!- FUNCTION: May regulate RNA splicing or metabolism in a specific
subset of developing neurons.
-!- SUBUNIT: Interacts with PTBP2; the interaction is direct.
{ECO:0000250}.
-!- SUBCELLULAR LOCATION: Nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=5;
Name=1;
IsoId=P51513-1; Sequence=Displayed;
Name=2; Synonyms=Tumor;
IsoId=P51513-2; Sequence=VSP_002841, VSP_002843, VSP_002844;
Name=3;
IsoId=P51513-3; Sequence=VSP_002842;
Name=4;
IsoId=P51513-4; Sequence=VSP_002841;
Name=5;
IsoId=P51513-5; Sequence=VSP_002841, VSP_002842;
Note=Gene prediction based on EST data.;
-!- TISSUE SPECIFICITY: Brain.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U04840; AAA16022.1; -; mRNA.
EMBL; AK289639; BAF82328.1; -; mRNA.
EMBL; AK291022; BAF83711.1; -; mRNA.
EMBL; AL079343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL132716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471078; EAW65990.1; -; Genomic_DNA.
EMBL; CH471078; EAW65991.1; -; Genomic_DNA.
EMBL; CH471078; EAW65992.1; -; Genomic_DNA.
EMBL; CH471078; EAW65993.1; -; Genomic_DNA.
EMBL; CH471078; EAW65995.1; -; Genomic_DNA.
EMBL; BC075038; AAH75038.1; -; mRNA.
EMBL; BC075039; AAH75039.1; -; mRNA.
EMBL; Z70771; CAA94810.1; -; mRNA.
CCDS; CCDS32060.1; -. [P51513-5]
CCDS; CCDS32061.1; -. [P51513-4]
CCDS; CCDS9635.1; -. [P51513-2]
PIR; I38489; I38489.
RefSeq; NP_002506.2; NM_002515.2. [P51513-4]
RefSeq; NP_006480.2; NM_006489.2. [P51513-5]
RefSeq; NP_006482.1; NM_006491.2. [P51513-2]
UniGene; Hs.31588; -.
PDB; 1DT4; X-ray; 2.60 A; A=424-495.
PDB; 2ANN; X-ray; 2.30 A; A=49-249.
PDB; 2ANR; X-ray; 1.94 A; A=49-249.
PDBsum; 1DT4; -.
PDBsum; 2ANN; -.
PDBsum; 2ANR; -.
ProteinModelPortal; P51513; -.
SMR; P51513; -.
BioGrid; 110919; 10.
IntAct; P51513; 8.
MINT; MINT-1381951; -.
STRING; 9606.ENSP00000438875; -.
iPTMnet; P51513; -.
PhosphoSitePlus; P51513; -.
BioMuta; NOVA1; -.
DMDM; 1709303; -.
EPD; P51513; -.
MaxQB; P51513; -.
PaxDb; P51513; -.
PeptideAtlas; P51513; -.
PRIDE; P51513; -.
TopDownProteomics; P51513-2; -. [P51513-2]
Ensembl; ENST00000344429; ENSP00000342387; ENSG00000139910. [P51513-2]
Ensembl; ENST00000465357; ENSP00000447391; ENSG00000139910. [P51513-5]
Ensembl; ENST00000539517; ENSP00000438875; ENSG00000139910. [P51513-4]
GeneID; 4857; -.
KEGG; hsa:4857; -.
UCSC; uc001wpy.4; human. [P51513-1]
CTD; 4857; -.
DisGeNET; 4857; -.
EuPathDB; HostDB:ENSG00000139910.19; -.
GeneCards; NOVA1; -.
H-InvDB; HIX0037755; -.
HGNC; HGNC:7886; NOVA1.
HPA; HPA004155; -.
MIM; 602157; gene.
neXtProt; NX_P51513; -.
OpenTargets; ENSG00000139910; -.
PharmGKB; PA31688; -.
eggNOG; KOG2191; Eukaryota.
eggNOG; ENOG410XRZD; LUCA.
GeneTree; ENSGT00760000119144; -.
HOGENOM; HOG000007833; -.
HOVERGEN; HBG082048; -.
InParanoid; P51513; -.
KO; K14944; -.
OMA; ANDFYPG; -.
OrthoDB; EOG091G185U; -.
PhylomeDB; P51513; -.
TreeFam; TF316981; -.
ChiTaRS; NOVA1; human.
EvolutionaryTrace; P51513; -.
GeneWiki; NOVA1; -.
GenomeRNAi; 4857; -.
PRO; PR:P51513; -.
Proteomes; UP000005640; Chromosome 14.
Bgee; ENSG00000139910; -.
CleanEx; HS_NOVA1; -.
ExpressionAtlas; P51513; baseline and differential.
Genevisible; P51513; HS.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
GO; GO:0005730; C:nucleolus; IDA:HPA.
GO; GO:0005634; C:nucleus; IDA:HPA.
GO; GO:0003729; F:mRNA binding; IEA:Ensembl.
GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
GO; GO:0007626; P:locomotory behavior; TAS:ProtInc.
GO; GO:0000398; P:mRNA splicing, via spliceosome; IEA:Ensembl.
GO; GO:0051252; P:regulation of RNA metabolic process; IEA:Ensembl.
GO; GO:0006396; P:RNA processing; TAS:ProtInc.
GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
Gene3D; 3.30.1370.10; -; 3.
InterPro; IPR004087; KH_dom.
InterPro; IPR004088; KH_dom_type_1.
InterPro; IPR036612; KH_dom_type_1_sf.
InterPro; IPR033086; NOVA1.
PANTHER; PTHR10288:SF223; PTHR10288:SF223; 1.
Pfam; PF00013; KH_1; 3.
SMART; SM00322; KH; 3.
SUPFAM; SSF54791; SSF54791; 3.
PROSITE; PS50084; KH_TYPE_1; 3.
1: Evidence at protein level;
3D-structure; Alternative splicing; Complete proteome; Nucleus;
Phosphoprotein; Reference proteome; Repeat; RNA-binding.
CHAIN 1 510 RNA-binding protein Nova-1.
/FTId=PRO_0000050116.
DOMAIN 49 119 KH 1. {ECO:0000255|PROSITE-
ProRule:PRU00117}.
DOMAIN 174 240 KH 2. {ECO:0000255|PROSITE-
ProRule:PRU00117}.
DOMAIN 424 491 KH 3. {ECO:0000255|PROSITE-
ProRule:PRU00117}.
MOTIF 27 43 Bipartite nuclear localization signal.
{ECO:0000255}.
COMPBIAS 276 412 Ala-rich.
MOD_RES 157 157 Phosphoserine.
{ECO:0000250|UniProtKB:Q9JKN6}.
VAR_SEQ 88 90 Missing (in isoform 2, isoform 4 and
isoform 5). {ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:15489334,
ECO:0000303|PubMed:8398153}.
/FTId=VSP_002841.
VAR_SEQ 153 176 Missing (in isoform 3 and isoform 5).
{ECO:0000303|PubMed:8398153}.
/FTId=VSP_002842.
VAR_SEQ 177 184 VKIIVPNS -> KHNISWIS (in isoform 2).
{ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:8398153}.
/FTId=VSP_002843.
VAR_SEQ 185 510 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:8398153}.
/FTId=VSP_002844.
STRAND 50 57 {ECO:0000244|PDB:2ANR}.
HELIX 58 65 {ECO:0000244|PDB:2ANR}.
HELIX 67 69 {ECO:0000244|PDB:2ANR}.
HELIX 70 79 {ECO:0000244|PDB:2ANR}.
STRAND 82 85 {ECO:0000244|PDB:2ANR}.
STRAND 98 107 {ECO:0000244|PDB:2ANR}.
HELIX 109 123 {ECO:0000244|PDB:2ANR}.
HELIX 148 151 {ECO:0000244|PDB:2ANR}.
STRAND 177 182 {ECO:0000244|PDB:2ANR}.
HELIX 183 190 {ECO:0000244|PDB:2ANR}.
HELIX 192 194 {ECO:0000244|PDB:2ANR}.
HELIX 195 203 {ECO:0000244|PDB:2ANR}.
STRAND 207 210 {ECO:0000244|PDB:2ANR}.
STRAND 221 229 {ECO:0000244|PDB:2ANR}.
HELIX 230 245 {ECO:0000244|PDB:2ANR}.
STRAND 425 432 {ECO:0000244|PDB:1DT4}.
TURN 433 436 {ECO:0000244|PDB:1DT4}.
HELIX 437 440 {ECO:0000244|PDB:1DT4}.
HELIX 442 444 {ECO:0000244|PDB:1DT4}.
HELIX 445 454 {ECO:0000244|PDB:1DT4}.
STRAND 457 460 {ECO:0000244|PDB:1DT4}.
STRAND 472 479 {ECO:0000244|PDB:1DT4}.
HELIX 481 494 {ECO:0000244|PDB:1DT4}.
SEQUENCE 510 AA; 52056 MW; 7B9BA8B67CAB6984 CRC64;
MMAAAPIQQN GTHTGVPIDL DPPDSRKRPL EAPPEAGSTK RTNTGEDGQY FLKVLIPSYA
AGSIIGKGGQ TIVQLQKETG ATIKLSKLSK SKDFYPGTTE RVCLIQGTVE ALNAVHGFIA
EKIREMPQNV AKTEPVSILQ PQTTVNPDRI KQTLPSSPTT TKSSPSDPMT TSRANQVKII
VPNSTAGLII GKGGATVKAV MEQSGAWVQL SQKPDGINLQ ERVVTVSGEP EQNRKAVELI
IQKIQEDPQS GSCLNISYAN VTGPVANSNP TGSPYANTAE VLPTAAAAAG LLGHANLAGV
AAFPAVLSGF TGNDLVAITS ALNTLASYGY NLNTLGLGLS QAAATGALAA AAASANPAAA
AANLLATYAS EASASGSTAG GTAGTFALGS LAAATAATNG YFGAASPLAA SAILGTEKST
DGSKDVVEIA VPENLVGAIL GKGGKTLVEY QELTGARIQI SKKGEFVPGT RNRKVTITGT
PAATQAAQYL ITQRITYEQG VRAANPQKVG


Related products :

Catalog number Product name Quantity
EIAAB27565 Homo sapiens,Human,Neuro-oncological ventral antigen 1,NOVA1,Onconeural ventral antigen 1,Paraneoplastic Ri antigen,RNA-binding protein Nova-1,Ventral neuron-specific protein 1
EIAAB27564 Mouse,Mus musculus,Neuro-oncological ventral antigen 1,Nova1,RNA-binding protein Nova-1,Ventral neuron-specific protein 1
EIAAB27563 Neuro-oncological ventral antigen 1,Nova1,Rat,Rattus norvegicus,RNA-binding protein Nova-1
EIAAB27566 ANOVA,Astrocytic NOVA1-like RNA-binding protein,Homo sapiens,Human,Neuro-oncological ventral antigen 2,NOVA2,NOVA3,RNA-binding protein Nova-2
NOX3 NOVA2 Gene neuro-oncological ventral antigen 2
E9783h Human Neuro Oncological Ventral Antigen 1 ELISA Ki 96T
E5657h Human Neuro Oncological Ventral Antigen 2 ELISA Ki 96T
NOX1 NOVA1 Gene neuro-oncological ventral antigen 1
201-20-3822 NOVA2{neuro-oncological ventral antigen 2}rabbit.pAb 0.2ml
GWB-AC492A Anti- NOVA2 (neuro-oncological ventral antigen 2) Antibody
GWB-8F3775 Anti- NOVA2 (neuro-oncological ventral antigen 2) Antibody
CSB-EL015957RA Rat neuro-oncological ventral antigen 1 (NOVA1) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL015957HU Human neuro-oncological ventral antigen 1 (NOVA1) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL015957MO Mouse neuro-oncological ventral antigen 1 (NOVA1) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL015958HU Human neuro-oncological ventral antigen 2 (NOVA2) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-PA015958GA01HU Rabbit anti-human neuro-oncological ventral antigen 2 polyclonal Antibody Primary antibody Host:Rabbit IgG 150ul
CSB-PA015958GA01HU Rabbit anti-human neuro-oncological ventral antigen 2 polyclonal Antibody Primary antibody Host:Rabbit IgG 50ul
EIAAB45715 Mouse,Mus musculus,Vax2,Ventral anterior homeobox 2,Ventral retina homeodomain protein,Vex
EIAAB30756 25dx,25-DX,Acidic 25 kDa protein,Lewi,Membrane-associated progesterone receptor component 1,Pgrmc,Pgrmc1,Rat,Rattus norvegicus,VEMA,Ventral midline antigen
29-288 NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are foun 0.05 mg
25-605 NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are foun 0.05 mg
EIAAB12771 ELAVL3,ELAV-like protein 3,Homo sapiens,Hu-antigen C,HuC,HUC,Human,Paraneoplastic cerebellar degeneration-associated antigen,Paraneoplastic limbic encephalitis antigen 21,PLE21
EIAAB31690 37 kDa neuronal protein,Homo sapiens,Human,MA1,Neuron- and testis-specific protein 1,Paraneoplastic antigen Ma1,PNMA1
EIAAB31693 40 kDa neuronal protein,Homo sapiens,Human,KIAA0883,MA2,Onconeuronal antigen Ma2,Paraneoplastic antigen Ma2,Paraneoplastic neuronal antigen MM2,PNMA2
E13601h Human Ventral Anterior Homeobox Protein 1 ELISA Ki 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur